The AHA, joined by the Association of American Medical Colleges and several member hospitals, yesterday asked the full U.S. Court of Appeals for the District of Columbia Circuit to rehear a July 17 decision by a three-judge panel that upheld the authority of the Department of Health and Human Services to reduce payments for hospital outpatient services furnished in off-campus provider-based departments grandfathered under the Bipartisan Budget Act of 2015. The panel upheld the payment reduction as a reasonable exercise of the agency’s statutory authority to control unnecessary increases in service volumes, relying on the legal theory announced in Chevron U.S.A. Inc. v. Natural Resources Defense Council Inc. (1984) that instructs a court to defer to such reasonable agency interpretation.  
 
Reversing a lower court decision in hospitals’ favor, the panel “sustained a draconian Centers for Medicare & Medicaid Services rulemaking by granting extraordinary deference to the agency that it neither sought nor earned,” the petitioners state. “To reach this result, the panel gave the wrong answer to several important, recurring Chevron questions.” They continue, “This case is not just important in the Chevron abstract. It is critically important in the here-and-now. It permits the Executive to unilaterally cut hundreds of millions of dollars from hospital outpatient clinics serving millions of patients across the country. Those deep cuts will be felt all the more now, as hospitals navigate the unprecedented challenges imposed by the pandemic.”

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Dec. 19 announced the creation of the Office of Rural Health Transformation. The office will oversee…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 18 that it will launch a voluntary payment model designed to broadly reach more…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…
Blog
Public
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4…
Headline
The Centers for Medicare & Medicaid Services Dec. 15 published the Measures Under Consideration List for 2025. These are measures that CMS is considering…
Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…